MHRA-100995-PIP01-23

Key Facts

Active Substance
Active Substance:
  • LysoPhosphatidic Acid receptor 1 (LPA1) antagonist (BMS-986278)
Invented Name
Not yet available
PIP Number MHRA-100995-PIP01-23
Pharmaceutical form(s)
Pharmaceutical form(s):
  • All pharmaceutical forms
Therapeutic area
Therapeutic area:
  • Pneumology - Allergology
Conditions / Indications
Conditions / Indications:
  • Treatment of fibrosing Interstitial Lung Diseases (ILD)
Route(s) of administration
Route(s) of administration:
  • All routes of administration
PIP applicant
Decision Type
Decision Type
W: decision granting a waiver in all age groups for the listed condition(s).
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):LysoPhosphatidic Acid receptor 1 (LPA1) antagonist (BMS-986278).pdf
Published Date 19/12/2023